Abstract:Yang Liu X-Ray Department, The No.1 People's Hospital of Huzhou, Huzhou, Zhejiang, 313000, People's Republic of China Correspondence: Yang Liu, X-ray department, The No.1 People's hospital of Huzhou, No. 158, Square Hou Road, Wuxing District, Huzhou, Zhejiang, 313000, People's Republic of China, Email Objective: To explore the value of the magnetic resonance imaging (MRI) radiomics model in predicting prostate cancer (PCa) invasion. Methods: Clinical data of 86 pathologically confirmed PCa patients in our hospital were collected, including 44 cases in the invasive group and 42 cases in the non-invasive group. All patients underwent MRI examinations, and the same parameters were used. The lesion area was manually delineated and the radiomics features were extracted from T2WI. The radiomics signature based on LASSO regression was established. Besides, logistic regression was used to identify independent clinical predictors, and a combined model incorporating the radiomics signature and independent clinical risk factor was constructed. Finally, the receiver operating characteristic curve (ROC) analysis and decision curve analysis (DCA) was performed to compare the prediction efficiency and clinical benefit of each model. Results: A total of 867 radiomics features were obtained, and six of them were incorporated into the radiomics model. Multivariate logistic regression analysis exhibited the Gleason score as an independent clinical risk factor for PCa invasion. ROC results showed that the performance of the radiomics model was comparable to that of the clinical-radiomics model in predicting PCa invasion, and it was better than that of the single Gleason score. DCA also confirmed the considerable clinical application value of the radiomics and the clinical-radiomics models. Conclusion: As a simple, non-invasive, and efficient method, the radiomics model has important predictive value for PCa invasion. Graphical Keywords: prostate cancer, invasion, magnetic resonance imaging, radiomics, machine learning Graphical Prostate cancer (PCa) is one of the most common malignant tumors and the second leading cause of death among men worldwide, threatening human life and health safety. 1,2 The morbidity of PCa is 60.3/100,000 in China, which is lower than 80.7/100,000 in European and American countries. With the change in diet structure, living environment, and the aggravation of population aging, its incidence has increased rapidly in China as well. 3 PCa screening through serum prostate-specific antigen testing and prostate biopsy has reduced mortality from advanced PCa over the past decade. 4 In a population of 3171 men who underwent prostate biopsy, 36.9% of them suffered from PCa: their PSA levels were <4 ng/mL in 8.8% of cases and <10 ng/mL in 51.8%. 5 However, in men over 70 years or in any men with less than a 10–15 year life expectancy, prostate-specific antigen was not recommended according to the American Urological Association due to unexpected overdiagnosis and overtreatment of low-risk and indolent prostate cancers. 6 In addition, the Gleason score serves as a key factor in predicting PCa invasion, which has become one of the main reference indicators for treatment decisions and prognosis evaluation. 7 Nevertheless, the Gleason score of PCa is qualitative and subjective, which requires invasive procedures to obtain tissue specimens, such as puncture, resection, or radical surgery, carrying the risk of infection and bleeding and may underestimate aggressiveness. 8 Therefore, it is of great significance to explore a simple, non-invasive, and efficient evaluation method for PCa invasion, guide treatment and improve the prognosis of patients. Magnetic resonance imaging (MRI) has been widely used to evaluate the heterogeneity of tumors and achieved high diagnostic efficiency. 9 Quantitative measurements based on MRI and PET/CT results including lymph node volume, primary tumor volume, and standard uptake values were closely related to clinical outcomes. 10,11 To achieve a more quantitative prediction approach, many studies have assessed the role of quantitative analysis of medical images, triggering the development of radiomics. Radiomics is a high-throughput extraction of a large number of medical image features from medical examination images and then conversion into minable high-dimensional data. 12 Radiomics features quantify properties related to tumor shape, texture, and image intensity, which may be predictive of the clinical outcomes and tumor characteristics. 13 Despite the evidence of the benefit of radiomics in predicting significant PCa, 14,15 few stu -Abstract Truncated-

Quantification of Multi-Parametric Magnetic Resonance Imaging Based on Radiomics Analysis for Differentiation of Benign and Malignant Lesions of Prostate

Bi-parametric magnetic resonance imaging based radiomics for the identification of benign and malignant prostate lesions: cross-vendor validation

Using biparametric MRI radiomics signature to differentiate between benign and malignant prostate lesions

Differential diagnosis of diffuse lesion in peripheral zone of prostate by using multi-parametric MRI

Radiomics Based on Biparametric MRI for the Detection of Significant Residual Prostate Cancer after Androgen Deprivation Therapy: Using Whole-Mount Histopathology As Reference Standard.

Multi-parametric MRI-based Radiomics Signature for Discriminating Between Clinically Significant and Insignificant Prostate Cancer: Cross-validation of a Machine Learning Method.

Biparametric MRI-based radiomics classifiers for the detection of prostate cancer in patients with PSA serum levels of 4∼10 ng/mL

Multi-parametric MRI Radiomics Analysis with Ensemble Learning for Prostate Lesion Classification.

Radiomics analysis for prostate cancer classification in multiparametric magnetic resonance images

MRI-based Radiomics Models to Assess Prostate Cancer, Extracapsular Extension and Positive Surgical Margins

Prostate lesion delineation from multiparametric magnetic resonance imaging based on locality alignment discriminant analysis.

Combining Magnetic Resonance Diffusion-Weighted Imaging with Prostate-Specific Antigen to Differentiate Between Malignant and Benign Prostate Lesions.

Multiparametric MRI and Machine Learning Based Radiomic Models for Preoperative Prediction of Multiple Biological Characteristics in Prostate Cancer

Predicting the Grade of Prostate Cancer Based on a Biparametric MRI Radiomics Signature

Validation of Quantitative Analysis of Multiparametric Prostate MR Images for Prostate Cancer Detection and Aggressiveness Assessment: a Cross-Imager Study.

Comparison of Magnetic Resonance Imaging-Based Radiomics Features with Nomogram for Prediction of Prostate Cancer Invasion

Evaluating Prostate Cancer: The Diagnostic Impact of MRI and Its Relationship With Transrectal Ultrasound (TRUS)-Guided Biopsy

Radiomics of Multiparametric MRI to Predict Biochemical Recurrence of Localized Prostate Cancer after Radiation Therapy

A radiomics based method for prediction of prostate cancer Gleason score using enlarged region of interest

Multi-view radiomics and deep learning modeling for prostate cancer detection based on multi-parametric MRI

MRI‐based radiomic features for identifying recurrent prostate cancer after proton radiation therapy